Riluzole in psychiatry: a systematic review of the literature

被引:70
作者
Zarate, Carlos A., Jr. [1 ]
Manji, Husseini K. [1 ]
机构
[1] NIMH, Lab Mol Pathophysiol & Expt Therapeut, Mood & Anxiety Disorders Res Program, Bethesda, MD 20892 USA
关键词
antidepressant; anxiety disorder; bipolar disorder; depression; glutamate; mania; plasticity; psychiatry; riluzole; treatment;
D O I
10.1517/17425255.4.9.1223
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: The glutamate system seems to be an important contributor to the pathophysiology of mood and anxiety disorders. Thus, glutamatergic modulators are reasonable candidate drugs to test in patients with mood and anxiety disorders. Riluzole, a neuroprotective agent with anticonvulsant properties approved for the treatment of amyotrophic lateral sclerosis (ALS) is one such agent. Objective: To assess the potential risks and benefits of riluzole treatment in psychiatric patients. Methods: A PubMed search was performed using the keywords 'riluzole', 'inhibitor of glutamate release' and 'glutamatergic modulator' to identify all clinical studies and case reports involving riluzole in psychiatric patients. Results/conclusion: Riluzole's side effect profile is favorable and preliminary results regarding riluzole for the treatment of severe mood, anxiety and impulsive disorders are encouraging.
引用
收藏
页码:1223 / 1234
页数:12
相关论文
共 92 条
[1]   Comparative neuroprotective effect of sodium channel blockers after experimental spinal cord injury [J].
Ates, Ozkan ;
Cayli, Suleyman R. ;
Gurses, Ilal ;
Turkoz, Yusuf ;
Tarim, Ozcan ;
Cakir, Celal O. ;
Kocak, Ayhan .
JOURNAL OF CLINICAL NEUROSCIENCE, 2007, 14 (07) :658-665
[2]   Riluzole increases high-affinity glutamate uptake in rat spinal cord synaptosomes [J].
Azbill, RD ;
Mu, X ;
Springer, JE .
BRAIN RESEARCH, 2000, 871 (02) :175-180
[3]  
BANSAR M, 2006, NEUROPSYCHOPHARMACOL
[4]   2-AMINO-6-TRIFLUOROMETHOXY BENZOTHIAZOLE, A POSSIBLE ANTAGONIST OF EXCITATORY AMINO-ACID NEUROTRANSMISSION .2. BIOCHEMICAL-PROPERTIES [J].
BENAVIDES, J ;
CAMELIN, JC ;
MITRANI, N ;
FLAMAND, F ;
UZAN, A ;
LEGRAND, JJ ;
GUEREMY, C ;
LEFUR, G .
NEUROPHARMACOLOGY, 1985, 24 (11) :1085-1092
[5]   RILUZOLE PREVENTS MPTP-INDUCED PARKINSONISM IN THE RHESUS-MONKEY - A PILOT-STUDY [J].
BENAZZOUZ, A ;
BORAUD, T ;
DUBEDAT, P ;
BOIREAU, A ;
STUTZMANN, JM ;
GROSS, C .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 284 (03) :299-307
[6]   A CONTROLLED TRIAL OF RILUZOLE IN AMYOTROPHIC-LATERAL-SCLEROSIS [J].
BENSIMON, G ;
LACOMBLEZ, L ;
MEININGER, V ;
BOUCHE, P ;
DELWAIDE, C ;
COURATIER, P ;
BLIN, O ;
VIADER, F ;
PEYROSTPAUL, H ;
DAVID, J ;
MALOTEAUX, JM ;
HUGON, J ;
LATERRE, EC ;
RASCOL, A ;
CLANET, M ;
VALLAT, JM ;
DUMAS, A ;
SERRATRICE, G ;
LECHEVALLIER, B ;
PEUCH, AJ ;
NGUYEN, T ;
SHU, C ;
BASTIEN, P ;
PAPILLON, C ;
DURRLEMAN, S ;
LOUVEL, E ;
GUILLET, P ;
LEDOUX, L ;
ORVOENFRIJA, E ;
DIB, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (09) :585-591
[7]   Hypersensitivity pneumonitis possibly caused by riluzole therapy in ALS [J].
Cassiman, D ;
Thomeer, M ;
Verbeken, E ;
Robberecht, W .
NEUROLOGY, 2003, 61 (08) :1150-U12
[8]   Efficacy screening trials of paroxetine, pentoxifylline, riluzole, pramipexole and venlafaxine in cocaine dependence [J].
Ciraulo, DA ;
Sarid-Segal, O ;
Knapp, CM ;
Ciraulo, AM ;
LoCastro, J ;
Bloch, DA ;
Montgomery, MA ;
Leiderman, DB ;
Elkashef, A .
ADDICTION, 2005, 100 :12-22
[9]   Liquid chromatographic determination of minocycline in brain-to-plasma distribution studies in the rat [J].
Colovic, M ;
Caccia, SB .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2003, 791 (1-2) :337-343
[10]   Liquid chromatographic assay for riluzole in mouse plasma and central nervous system tissues [J].
Colovic, M ;
Zennaro, E ;
Caccia, S .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2004, 803 (02) :305-309